FR3083984A1 - Dispositif pour injecter une solution d'insuline(s) - Google Patents

Dispositif pour injecter une solution d'insuline(s) Download PDF

Info

Publication number
FR3083984A1
FR3083984A1 FR1856817A FR1856817A FR3083984A1 FR 3083984 A1 FR3083984 A1 FR 3083984A1 FR 1856817 A FR1856817 A FR 1856817A FR 1856817 A FR1856817 A FR 1856817A FR 3083984 A1 FR3083984 A1 FR 3083984A1
Authority
FR
France
Prior art keywords
insulin
injecting
reservoir
insulin solution
accelerator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR1856817A
Other languages
English (en)
Inventor
Rémi Soula
Olivier Soula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adocia SAS
Original Assignee
Adocia SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adocia SAS filed Critical Adocia SAS
Priority to FR1856817A priority Critical patent/FR3083984A1/fr
Priority to PCT/EP2019/066600 priority patent/WO2019243627A1/fr
Publication of FR3083984A1 publication Critical patent/FR3083984A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/1782—Devices aiding filling of syringes in situ
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/24—Check- or non-return valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2066—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2448—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3294—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub

Abstract

L'invention concerne un dispositif pour injecter ou transférer une solution d'insuline (s), agencé pour la fabrication in situ, ou préparation extemporanée, d'une solution d'insuline (s) comprenant un accélérateur de l'insuline, prête à l'emploi. Ledit dispositif comprend un réservoir, ledit réservoir comprenant un accélérateur de l'insuline sous forme solide ou sous forme liquide et ledit réservoir étant dépourvu d'insuline. L'invention concerne également une seringue comprenant un réservoir et comprenant un accélérateur de l'insuline sous forme solide.
FR1856817A 2018-06-23 2018-07-23 Dispositif pour injecter une solution d'insuline(s) Withdrawn FR3083984A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1856817A FR3083984A1 (fr) 2018-07-23 2018-07-23 Dispositif pour injecter une solution d'insuline(s)
PCT/EP2019/066600 WO2019243627A1 (fr) 2018-06-23 2019-06-24 Dispositif pour injecter une solution d'insuline(s)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1856817A FR3083984A1 (fr) 2018-07-23 2018-07-23 Dispositif pour injecter une solution d'insuline(s)

Publications (1)

Publication Number Publication Date
FR3083984A1 true FR3083984A1 (fr) 2020-01-24

Family

ID=65200913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1856817A Withdrawn FR3083984A1 (fr) 2018-06-23 2018-07-23 Dispositif pour injecter une solution d'insuline(s)

Country Status (1)

Country Link
FR (1) FR3083984A1 (fr)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298585A1 (fr) * 1987-07-08 1989-01-11 Duoject Medical Systems Inc Seringue
WO1991009617A1 (fr) 1989-12-21 1991-07-11 Novo Nordisk A/S Preparations d'insuline contenant de l'acide nicotinique ou de la nicotinamide
WO2009048959A1 (fr) 2007-10-09 2009-04-16 Biodel, Inc. Compositions d'insuline injectable à action rapide
WO2009134380A2 (fr) 2008-04-28 2009-11-05 Halozyme, Inc. Compositions d'insuline à action super-rapide
WO2010102020A1 (fr) 2009-03-03 2010-09-10 Biodel Inc. Formulations d'insuline pour une absorption rapide
WO2010149772A1 (fr) 2009-06-26 2010-12-29 Novo Nordisk A/S Préparation contenant de l'insuline, du nicotinamide et un acide aminé
WO2012080362A1 (fr) 2010-12-14 2012-06-21 Novo Nordisk A/S Préparation comportant de l'insuline, du nicotinamide et un acide aminé
WO2013158618A1 (fr) 2012-04-16 2013-10-24 Biodel Inc. Compositions de magnésium pour moduler la pharmacocinétique et la pharmacodynamique de l'insuline et d'analogues de l'insuline, et la douleur au site d'injection
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
WO2014076423A1 (fr) 2012-11-13 2014-05-22 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
WO2015120457A1 (fr) 2014-02-10 2015-08-13 Biodel Inc. Formulations d'insuline à action ultrarapide stabilisées
US20160144104A1 (en) 2014-11-26 2016-05-26 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
WO2017001925A1 (fr) * 2015-07-02 2017-01-05 Marc Andrew Koska Dispositif de distribution à usage unique pré-rempli d'un agent reconstituable
WO2017034956A1 (fr) 2015-08-27 2017-03-02 Eli Lilly And Company Compositions d'insuline à action rapide

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298585A1 (fr) * 1987-07-08 1989-01-11 Duoject Medical Systems Inc Seringue
WO1991009617A1 (fr) 1989-12-21 1991-07-11 Novo Nordisk A/S Preparations d'insuline contenant de l'acide nicotinique ou de la nicotinamide
WO2009048959A1 (fr) 2007-10-09 2009-04-16 Biodel, Inc. Compositions d'insuline injectable à action rapide
WO2009134380A2 (fr) 2008-04-28 2009-11-05 Halozyme, Inc. Compositions d'insuline à action super-rapide
WO2010102020A1 (fr) 2009-03-03 2010-09-10 Biodel Inc. Formulations d'insuline pour une absorption rapide
WO2010149772A1 (fr) 2009-06-26 2010-12-29 Novo Nordisk A/S Préparation contenant de l'insuline, du nicotinamide et un acide aminé
WO2012080362A1 (fr) 2010-12-14 2012-06-21 Novo Nordisk A/S Préparation comportant de l'insuline, du nicotinamide et un acide aminé
WO2013158618A1 (fr) 2012-04-16 2013-10-24 Biodel Inc. Compositions de magnésium pour moduler la pharmacocinétique et la pharmacodynamique de l'insuline et d'analogues de l'insuline, et la douleur au site d'injection
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
WO2014076423A1 (fr) 2012-11-13 2014-05-22 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
WO2015120457A1 (fr) 2014-02-10 2015-08-13 Biodel Inc. Formulations d'insuline à action ultrarapide stabilisées
US20160144104A1 (en) 2014-11-26 2016-05-26 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
WO2017001925A1 (fr) * 2015-07-02 2017-01-05 Marc Andrew Koska Dispositif de distribution à usage unique pré-rempli d'un agent reconstituable
WO2017034956A1 (fr) 2015-08-27 2017-03-02 Eli Lilly And Company Compositions d'insuline à action rapide

Similar Documents

Publication Publication Date Title
Steinstraesser et al. Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
MA40094A1 (fr) Protéines de fusion de l'interleukine-2/récepteur alpha de l'interleukine-2 et procédés d'utilisation
Weiss et al. Reasons for high drop-out rate with self-injection therapy for impotence.
PL1820730T3 (pl) Maszyna dawkująca do płynu radioaktywnego
MA34850B1 (fr) Composition granulaire hydro-dispersible
MA38698B1 (fr) Système d'administration transdermique
WO2008122360A3 (fr) Dispositif d'administration d'une principe actif fluide depuis une ampoule multicavité
NL187611C (nl) Sterilisatie-hulpstuk, bestemd voor plaatsing op het naaldhoudereinde van een injectiespuit.
SE7704331L (sv) Ampoule-seringue non-reutillisable, pre-remplie d'une substance medicamenteuse, prete a l'emploi
Ji et al. Niche-dependent regulations of metabolic balance in high-fat diet–induced diabetic mice by mesenchymal stromal cells
MA34296B1 (fr) Composition retard injectable antipsychotique
MA41138B1 (fr) Formulation à rapport fixe d'insuline glargine/lixisenatide
MA37777B1 (fr) Préparation pharmaceutique
Stoltenburg-Didinger Neuropathology of the hippocampus and its susceptibility to neurotoxic insult.
MA42287B1 (fr) Traitement de patients atteints de diabète sucré de type 2
Pellegrini et al. A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone
FR3083984A1 (fr) Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr) Dispositif pour injecter une solution d'insuline(s)
Engelhardt et al. Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology.
Goldstein Impotence.
Sparwasser et al. Long-term results of therapy with intracavernousal injections and penile venous surgery in chronic erectile dysfunction.
Tschuppert et al. Transient subfoveal fluid and visual loss after ocriplasmin
FR3091485B1 (fr) Capsule pour composition d’aromathérapie et dispositif de diffusion pour l’utilisation d’une telle capsule
O'Dell et al. SAT0162 switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritis
Trapp Pharmacologic erection program for the treatment of male impotence.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200124

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20220305